Mode
Text Size
Log in / Sign up
N/A N=129 Randomized Single-blind Treatment

Attachment Based Family Therapy for Suicidal Adolescents

Suicide · Depression · Family Relationships

Enrolled (actual)
129
Serious AEs
0.0%
Results posted
Feb 2018
Primary outcome: Primary: Change in the Intensity of Suicidal Ideation Between Intake and End of Treatment — -27.42; -31.55 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Attachment-Based Family Therapy (Behavioral); Family-Enhanced Non-directive Supportive Therapy (Behavioral)
Age
Pediatric, Adult · 12+ yrs
Sex
All
Sponsor
Drexel University
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in the Intensity of Suicidal Ideation Between Intake and End of Treatment
-27.42; -31.55
PRIMARY
Change in the Severity of Depression Symptoms Between Intake and End of Treatment
-4.87; -5.40
SECONDARY
Change in the Evidence of Family Conflict Between Parent and Youth After Intervention Between Intake and End of Treatment
-1.058; -1.2538

Summary

This study will evaluate the efficacy of attachment based family therapy (ABFT) for treatment of suicidality in adolescents. The study will compare 16 weeks of treatment with ABFT to a control condition Family Enhanced Non-directive Supportive Therapy (FE-NST).

Eligibility Criteria

Inclusion Criteria

  • Adolescents between the ages of 12 and 18
  • Adolescents endorse severe suicidal ideation (SIQ-JR > 31) and moderate depression (BDI-II > 20) at two time points (1 to 3 days)
  • At least one primary parent or caregiver must participate in the assessment and treatment. This could be a biological parent, stepparent, grandparent, other relative, or a foster parent, who has at least frequent contact with the subject. When possible both parents will participate in the assessment and treatment. Legal custody is always considered (e.g., divorced parents). Having all family members present at every session is not required. Many individual meetings with the subject or the parent are planned in both treatments.

Exclusion Criteria

  • Evidence of imminent risk of harm to self or others that cannot be safely treated on an outpatient basis
  • Evidence of psychotic features [as reported on the Diagnostic Interview Schedule for Children; Voice Diagnostic Interview Schedule for Children (VDISC)]
  • Evidence of suffering from severe cognitive impairment (e.g., mental retardation, severe developmental disorders) as evidenced by educational records, parental report and/or clinical impression).
  • Subjects taking antidepressant medication for depression for less than 6 weeks prior to the screening.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01537419). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search